Page 3 - B Pfizer News Today

The World Health Organization is creating a global training center to help poorer countries make vaccines, antibodies and cancer treatments using the messenger RNA technology that has successfully been used to make COVID-19 vaccines.

The Food and Drug Administration on Friday postponed an advisory meeting on Pfizer-BioNTech's vaccine for young children and will wait for data on the third dose from trials, meaning the rollout for ages 0 to 4 might not begin until April.

The Food and Drug Administration on Friday postponed an advisory meeting on Pfizer-BioNTech's vaccine for young children and will wait for data on the third dose from trials, meaning the rollout for ages 0 to 4 might not begin until April.

Herd immunity projection was just one of the areas where COVID-19 has humiliated policymakers and experts who have tried to lead the U.S. through the pandemic.

Herd immunity projection was just one of the areas where COVID-19 has humiliated policymakers and experts who have tried to lead the U.S. through the pandemic.

U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.

U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.

Pfizer and BioNTech are reportedly preparing to ask the Food and Drug Administration to authorize a COVID-19 vaccine for kids younger than 5.

U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third -- and potentially necessary -- shot is available.

U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children six months to 5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February, a person familiar with the matter told The Associated Press Monday.